Vaccination against pneumococcal infections
Prevenar 13
Composition and form of release:
- Prevenar 13 is a pneumococcal polysaccharide conjugated pneumococcal vaccine (13-valent).
- Suspension for intramuscular injection 0.5 ml/dose.
- In a single dose (0.5 ml) in a disposable syringe complete with injection needle.
- Manufacturer: Pfizer Ireland Pharmaceuticals, Ireland.
Indications:
Prevention of pneumococcal infections such as:
Prevention of pneumococcal infections such as:
- out-of-hospital pneumonias,
- otitis media,
- meningitis,
- bacteremia,
- sepsis.
Age recommendations and vaccination schedule:
- Vaccination is given at 2, 3, and 12 months of age.
- If the child has not received the Prevenar 13 vaccine before age 2, a single injection is given.
Method of administration:
- The vaccine is administered in a single dose of 0.5 ml, intramuscularly.
- Children of the first years of life, the vaccine is injected into the upper-outer surface of the middle third of the thigh.
- Persons older than 2 years of age - in the deltoid muscle of the shoulder.
Contraindications:
- Hypersensitivity to previous administration of Prevenar 13 or Prevenar (including anaphylactic shock and severe generalized allergic reactions).
- Hypersensitivity to diphtheria anatoxin and/or excipients.
- Infectious or non-infectious diseases in the period of exacerbation. Vaccination is carried out after recovery or during remission.
Before vaccination, be sure to be examined by a pediatrician.
Your child's health is our priority
Our clinic provides comprehensive medical care for newborns, infants and children.
Sign up for vaccination